B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ribociclib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ribociclib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

voruciclib
4 shared targets
ct
4 shared targets
palbociclib
8 shared targets
ebvaciclib
3 shared targets
momelotinib
9 shared targets
roniciclib
3 shared targets
fascaplysin
2 shared targets
atuveciclib
4 shared targets
abemaciclib
9 shared targets
bdb
2 shared targets
Loading evidence profile...

This evidence profile for Ribociclib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.